UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis

被引:924
作者
Stratton, IM
Kohner, EM
Aldington, SJ
Turner, RC
Holman, RR
Manley, SE
Matthews, DR
机构
[1] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford OX1 2JD, England
[2] St Thomas Hosp, Dept Med, London, England
[3] Imperial Coll Sch Med, Retinopathy Grading Ctr, London, England
[4] Radcliffe Infirm, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX2 6HE, England
关键词
Type II (non-insulin-dependent) diabetes; mellitus; retinopathy; randomised clinical trial; risk factors; incidence; progression; smoking; hypertension; glycaemia; HbA(1c);
D O I
10.1007/s001250051594
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Aims/hypothesis. To determine risk factors related to the incidence and progression of diabetic retinopathy over 6 years from diagnosis of Type II (non-insulin-dependent) diabetes mellitus. Methods. This report describes 1919 patients from within the United Kingdom Prospective Diabetes Study (UKPDS), with retinal photographs taken at diagnosis and 6 years later and with complete data available. Photographs were centrally graded for lesions of diabetic retinopathy using the modified Early Treatment of Diabetic Retinopathy Study Final scale. Risk factors were assessed after 3 months diet from the time of diagnosis of diabetes. Patients were seen every 3 months in a hospital setting. Biochemical measurements were done by a central laboratory. End points of vitreous haemorrhage and photocagulation were confirmed by independent adjudication of systematically collected clinical data. The main outcome measures were incidence and progression of retinopathy defined as a two-step Early Treatment of Diabetic Retinopathy Study (ETDRS) final scale change. Results. Of the 1919 patients, 1216 (63%) had no retinopathy at diagnosis. By 6 years, 22% of these had developed retinopathy, that is microaneurysms in both eyes or worse. In the 703 (37%) patients with retinopathy at diagnosis, 29% progressed by two scale steps or more. Development of retinopathy (incidence) was strongly associated with baseline glycaemia, glycaemic exposure over 6 years, higher blood pressure and with not smoking. In those who already had retinopathy, progression was associated with older age, male sex, hyperglycaemia las evidenced by a higher HbA(1c)) and with not smoking. Conclusion/interpretation. The findings re-emphasise the need for good glycaemic control and assiduous treatment of hypertension if diabetic retinopathy is to be minimised.
引用
收藏
页码:156 / 163
页数:8
相关论文
共 39 条
[1]
[Anonymous], 1983, Diabetologia, V24, P404
[2]
Biesenbach G, 1997, CLIN NEPHROL, V48, P146
[3]
*BMDP, 1990, BMDP STAT SOFTW MAN
[4]
*DECL TSV, 1990, DIABETIC MED, V7, P360
[5]
*EARL TREATM DIAB, 1985, EARLY TREATMENT DIAB, pCH12
[6]
PUBLICATION BIAS IN CLINICAL RESEARCH [J].
EASTERBROOK, PJ ;
BERLIN, JA ;
GOPALAN, R ;
MATTHEWS, DR .
LANCET, 1991, 337 (8746) :867-872
[7]
Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus [J].
Fujisawa, T ;
Ikegami, H ;
Yamato, E ;
Kawaguchi, Y ;
Ueda, H ;
Shintani, M ;
Nojima, K ;
Kawabata, Y ;
Ono, M ;
Nishino, T ;
Noso, S ;
Yamada, K ;
Babaya, N ;
Okamoto, N ;
Ohguro, N ;
Fukuda, M ;
Ogihara, T .
DIABETIC MEDICINE, 1999, 16 (06) :522-526
[8]
GROUP EDP, 1999, DIABETIC MED, V16, P716
[9]
Guillausseau PJ, 1998, DIABETIC MED, V15, P151, DOI 10.1002/(SICI)1096-9136(199802)15:2<151::AID-DIA527>3.3.CO
[10]
2-9